💨 Abstract

The UK will exclude Chinese ingredients from medicines exported to the US as part of a new trade pact. This move, influenced by U.S. pressure, aims to prevent the UK from being a "backdoor" for Chinese goods. While medicines for British patients can still include Chinese components, the UK's heavy reliance on Chinese pharmaceutical ingredients raises concerns. China criticized the deal, while campaigners urge the UK to further diversify its supply chain.

Courtesy: www.thesun.co.uk